NCT01398306View on ClinicalTrials.gov

Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
CarcinomaCarcinoma, Renal CellNeuroendocrine TumorsCarcinoid TumorPancreatic Islet Cell Tumors
Interventions
OTHER

Blood sampling by vena punction.

We obtain 10mL blood of the patients. The blood is obtained twice: once with angiogenesis inhibitors or mTOR inhibitors, and once without.

Trial Locations (1)

9700RB

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT01398306 - Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. | Biotech Hunter | Biotech Hunter